{"nct_id":"NCT04812535","title":"Non-comparative Study of IFX-1 Alone or IFX-1+Pembrolizumab in Patients With Locally Advanced or Metastatic cSCC.","status":"TERMINATED","status_verified_date":"2025-01","start_date":"2021-03-31","start_date_type":"ACTUAL","primary_completion_date":"2024-06-04","primary_completion_date_type":"ACTUAL","completion_date":"2024-06-04","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["IFRX"]}